Our Services
Medical Information
Helpful Resources
Published on: 10/26/2026
Venlafaxine (Effexor) can raise blood pressure in a dose-dependent way, trigger heavy sweating and night sweats, and cause a notably difficult discontinuation syndrome with dizziness, "brain zaps," nausea, and irritability when doses are missed or stopped abruptly. Higher daily doses, typically above 150 mg, carry the greatest hypertension risk, which is why periodic blood pressure monitoring and a slow, supervised taper matter so much. Sweating may improve over time or respond to dose adjustments and other strategies, and timing, formulation, and individual health history all change how these effects show up. There are several important factors to consider before assuming your symptoms are harmless or unrelated, so see below to understand more.
If you are noticing new sweating, blood pressure changes, or withdrawal-like symptoms and are unsure whether they stem from your medication, something else, or both, a free, instant, online symptom check can help you sort out likely causes in minutes and show you which next steps deserve urgent attention versus a routine conversation with your prescriber.
Last reviewed for medical accuracy: 10/22/2026
Venlafaxine (brand name Effexor) is a serotonin-norepinephrine reuptake inhibitor (SNRI) commonly prescribed for depression, generalized anxiety disorder and other mood conditions. While many users benefit from relief of symptoms, it’s important to understand the potential side effects of venlafaxine—especially changes in blood pressure, increased sweating and withdrawal symptoms when stopping the drug.
Venlafaxine boosts levels of serotonin and norepinephrine in the brain, which can improve mood, concentration and energy. It typically takes 4–6 weeks to see full benefit. Doses range from 37.5 mg up to 225 mg daily, depending on the condition treated and individual response.
Most people tolerate venlafaxine well, but some side effects occur in 10% or more of users:
These often improve over days to weeks. If they persist or worsen, talk with your doctor about adjusting your dose or switching medications.
One of the well-documented side effects of venlafaxine is an increase in blood pressure, especially at higher doses.
Sweating is another commonly reported side effect of venlafaxine.
Stopping venlafaxine abruptly can trigger a “discontinuation syndrome” that may be more intense than with other antidepressants.
While rare, be aware of:
If you notice any alarming signs—high fever, rash, severe headache, vision changes, chest pain—seek medical attention right away.
Your healthcare provider can adjust your dose, recommend treatments for side effects, or switch you to a different antidepressant if needed. Never stop venlafaxine suddenly without medical guidance—doing so increases the risk of withdrawal symptoms.
This overview of the side effects of venlafaxine is based on credible sources, including prescribing information and clinical guidelines. Always speak to a doctor about any concerns or symptoms that could be serious—they can give you personalized advice and ensure your treatment is safe and effective.
(References)
* Horsmans Y, De Clercq M, Sempoux C. Venlafaxine-associated hepatitis. Ann Intern Med. 1999 Jun 1;130(11):944. doi: 10.7326/0003-4819-130-11-199906010-00014. PMID: 10375350.
* Sheehan DV. Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder. J Clin Psychiatry. 1999;60 Suppl 22:23-8. PMID: 10634352.
* Cardona X, Avila A, Castellanos P. Venlafaxine-associated hepatitis. Ann Intern Med. 2000 Mar 7;132(5):417. doi: 10.7326/0003-4819-132-5-200003070-00016. PMID: 10691596.
* Linnebur SA, Saseen JJ, Pace WD. Venlafaxine-associated vaginal bleeding. Pharmacotherapy. 2002 May;22(5):652-5. doi: 10.1592/phco.22.8.652.33219. PMID: 12013367.
* Claassen JA, Gelissen HP. The serotonin syndrome. N Engl J Med. 2005 Jun 9;352(23):2454-6; author reply 2454-6. PMID: 15948274.
* Arroyo VC, Hallal H, Agudo JL, Aniorte JP. [Venlafaxine-induced cholestatic hepatitis]. Gastroenterol Hepatol. 2009 May;32(5):382-3. doi: 10.1016/j.gastrohep.2008.11.012. Epub 2009 May 13. PMID: 19442411.
* Ceylan ME, Evrensel A. Venlafaxine induced akathisia: a case report. Trends Psychiatry Psychother. 2016 Apr-Jun;38(2):117. doi: 10.1590/2237-6089-2015-0084. PMID: 27409139.
* Smischney NJ, Pollard EM, Nookala AU, Olatoye OO. Serotonin Syndrome in the Perioperative Setting. Am J Case Rep. 2018 Jul 16;19:833-835. doi: 10.12659/AJCR.909497. Epub 2018 Jul 16. PMID: 30008467; PMCID: PMC6061453.
* Özden HC, Gürel ŞC. Neuroleptic Malignant Syndrome with Low-dose Quetiapine After Venlafaxine Withdrawal: A Case Report. Turk Psikiyatri Derg. 2025;36:26. doi: 10.5080/u27497. Epub 2024 Sep 19. PMID: 41070489; PMCID: PMC11987542.
* Terao I. Clinical relevance of venlafaxine ER for generalized anxiety disorder. Psychiatry Clin Neurosci. 2026 Apr;80(4):358. doi: 10.1111/pcn.13924. Epub 2025 Nov 19. PMID: 41255146.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.